The groundbreaking rise of Viagra has long been a example of pharmaceutical success, yet its legacy read more within the broader sector now triggers questions about potential returns . Generic versions are eroding market share, leading to concerns that investing in companies heavily reliant to Viagra's once-dominant standing could be a problematic